Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy
Derry K. Mercer(NovaBiotics (United Kingdom)), Alfredo M. Angeles‐Boza(University of Connecticut), Deborah A. O′Neil(NovaBiotics (United Kingdom)), Maren von Köckritz‐Blickwede(University of Liverpool), Laura W. Simpson(NovaBiotics (United Kingdom)), Emma Lovie(NovaBiotics (United Kingdom)), Searle S. Duay(University of Connecticut), Marcelo D. T. Torres(Translational Therapeutics (United States)), César de la Fuente‐Núñez(Translational Therapeutics (United States))
Cited by 130
Related Papers
Peptide Design Principles for Antimicrobial Applications
|Journal of Molecular Biology|2019|439
Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis
|Cell|2019|427
In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
|Nature Communications|2018|285